Horm Metab Res 2014; 46(05): 354-359
DOI: 10.1055/s-0033-1363224
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Differential Impact of Changes in Adiposity Distribution on Insulin Resistance and Adiponectin Variations Over 4 Years in Normal Weight Young Adults

G. Lacerte
1   Centre de recherche clinique Etienne-LeBel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada
,
M.-F. Langlois
1   Centre de recherche clinique Etienne-LeBel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada
2   Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC, Canada
,
M. Doyon
1   Centre de recherche clinique Etienne-LeBel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada
,
C. Brown
1   Centre de recherche clinique Etienne-LeBel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada
,
A. C. Carpentier
1   Centre de recherche clinique Etienne-LeBel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada
2   Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC, Canada
,
M.-F. Hivert
1   Centre de recherche clinique Etienne-LeBel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada
2   Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC, Canada
3   General Medicine Division, Massachusetts General Hospital, Boston, MA, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 07. Juli 2013

accepted 19. November 2013

Publikationsdatum:
20. Januar 2014 (online)

Abstract

The aim of the study was to evaluate the influence of weight gain and changes in adiposity distribution on insulin resistance and circulating adiponectin variations over 4 years in free-living normal weight young adults. In this prospective observational cohort (n=42 women, 18 men), anthropometric measurements and blood samples were collected in the fasting state at baseline and at 4 years. Insulin resistance was estimated using the homeostatic model assessment (HOMA-IR). Circulating adiponectin levels were determined by radioimmunoassay. To investigate increase in adiposity more specifically, subsidiary analyses were performed in a subgroup of individuals (n=31) who gained adiposity over the course of the 4-year follow-up (defined as gain >1% in percent body fat). Regression analyses were performed to adjust for sex, age, parental education, lifestyle, and fitness levels. At baseline, the participants were young adults (age=20.0 years old) in the normal weight range [body mass index (BMI)=22.7 kg/m2 (IQR=21.1–24.4)]. Median change in body fat percentage was +1.4% (IQR=−0.3–3.4; p=0.01) and in waist circumference was +1.2 cm (IQR=−2.6–5.3; p=0.05). In the subgroup of individuals who gained more than 1% body fat, increase in HOMA-IR was associated with an increase in BMI (r=0.44; p=0.01; p<0.01 in fully adjusted model), while decrease in adiponectin levels was associated with an increase in waist circumference (r=−0.38; p=0.03) but this was no longer significant after adjustment for sex and other potential confounders (p=0.14). In a population of young adults, small variations in adiposity within the normal weight range were associated with increase in insulin resistance.

Supporting Information

 
  • References

  • 1 Gotay CC, Katzmarzyk PT, Janssen I, Dawson MY, Aminoltejari K, Bartley NL. Updating the canadian obesity maps: An epidemic in progress. Can J Public Health 2012; 104: 64-68
  • 2 Norman JE, Bild D, Lewis CE, Liu K, West DS. CARDIA Study . The impact of weight change on cardiovascular disease risk factors in young black and white adults: The CARDIA study. Int J Obes Relat Metab Disord 2003; 27: 369-376
  • 3 Hu FB. Overweight and obesity in women: Health risks and consequences. J Womens Health (Larchmt) 2003; 12: 163-172
  • 4 Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969
  • 5 Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846
  • 6 Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RBS, Wilson PW, Meigs JB. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008; 93: 3165-3172
  • 7 Stefan N, Stumvoll M. Adiponectin – its role in metabolism and beyond. Horm Metab Res 2002; 34: 469-474
  • 8 Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I. Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb 2011; 18: 592-595
  • 9 Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2009; 302: 179-188
  • 10 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
  • 11 Weller IM, Thomas SG, Gledhill N, Paterson D, Quinney A. A study to validate the modified canadian aerobic fitness test. Can J Appl Physiol 1995; 20: 211-221
  • 12 Shephard RJ, Thomas S, Weller I. The canadian home fitness test. 1991 update. Sports Med 1991; 11: 358-366
  • 13 Statistics Canada Population Health Surveys. Canadian Community Health Survey. 2004; Retrieved June 27, 2013 from http://www.statcan.gc.ca/concepts/hs-es/index-eng.htm
  • 14 Garriguet DM. Canadians’ eating habits. Health Reports, Statistics Canada 2007 Catalogue 82-003 Vol. 18, No. 2. Retrieved June 27, 2013 from http://www.statcan.gc.ca/pub/82-003-x/2006004/article/habit/9609-eng.pdf
  • 15 Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs Jr DR. Serum adiponectin in young adults – interactions with central adiposity, circulating levels of glucose, and insulin resistance: The CARDIA study. Ann Epidemiol 2004; 14: 492-498
  • 16 Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K, Andersen M. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009; 94: 4010-4015
  • 17 Jain SH, Massaro JM, Hoffmann U, Rosito GA, Vasan RS, Raji A, O’Donnell CJ, Meigs JB, Fox CS. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the framingham heart study. Diabetes Care 2009; 32: 903-908
  • 18 Saito T, Murata M, Otani T, Tamemoto H, Kawakami M, Ishikawa SE. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J 2012; 59: 39-45
  • 19 Hivert MF, Sullivan LM, Shrader P, Fox CS, Nathan DM, D’Agostino RBS, Wilson PW, Kowall B, Herder C, Meisinger C, Thorand B, Rathmann W, Meigs JB. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: The cooperative health research in the region of Augsburg (KORA) S4/F4 study and the framingham offspring study. Diabetologia 2011; 54: 1019-1024
  • 20 Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 2008; 294: E568-E575
  • 21 Folsom AR, Jacobs Jr DR, Wagenknecht LE, Winkhart SP, Yunis C, Hilner JE, Savage PJ, Smith DE, Flack JM. Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. the CARDIA study. coronary artery risk development in young adults. Am J Epidemiol 1996; 144: 235-246
  • 22 Kasparek DG, Corwin SJ, Valois RF, Sargent RG, Morris RL. Selected health behaviors that influence college freshman weight change. J Am Coll Health 2008; 56: 437-444
  • 23 Crombie AP, Ilich JZ, Dutton GR, Panton LB, Abood DA. The freshman weight gain phenomenon revisited. Nutr Rev 2009; 67: 83-94